Authors
Loading...
Preclinical study reveals that metabolic pathways and impaired nerve perfusion drive diabetic neuropathy, suggesting multi-action therapies restore nerve function.
Cameron et al. (1997) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: